|
| Lp-a < 300 mg/L (n = 147) | Lp-a ≥ 300 mg/L (n = 64) | p |
| MACE | 15 (10.2%) | 17 (26.6%) | 0.002* |
LDL_C | CR | 13 (8.8%) | 14 (21.9%) | 0.009* |
<1.8 mmol | Stroke | 0 (0%) | 2 (3.1%) | 0.031* |
(n = 211) | Death | 1 (0.7%) | 0 (0%) | 0.508 |
| MI | 1 (0.7%) | 1 (1.6%) | 0.543 |
|
| Lp-a < 300 mg/L (n = 109) | Lp-a≥300 mg/L (n = 104) | p |
LDL-C | MACE | 18 (16.5%) | 37 (35.6%) | 0.001* |
≥1.8 mmol/L | CR | 10 (9.2%) | 24 (23.1%) | 0.006* |
(n = 213) | Stroke | 3 (2.8%) | 4 (3.8%) | 0.654 |
| Death | 2 (1.8%) | 4 (3.8%) | 0.375 |
| MI | 3 (2.8%) | 5 (4.8%) | 0.430 |